1. Claypool WD, Rogers RM, Matuschak GM. Update on the clinical diagnosis, management, and pathogenesis of pulmonary alveolar proteinosis (phospho-lipidosis). Chest. 1984; 85:550–8.
Article
2. Rosen SH, Castleman B, Liebow AA. Pulmonary alveolar proteinosis. N Engl J Med. 1958; 258:1123–42.
Article
3. Prakash UB, Barham SS, Carpenter HA, Dines DE, Marsh HM. Pulmonary alveolar phospholipiproteinosis, experience with 34 cases and a review. Mayo Clin Proc. 1987; 62:499–518.
4. Trapnell BC, Whitsett JA, Nakata K. Pulmonary alveolar proteinosis. N Engl J Med. 2003; 349:2527–39.
Article
5. Dranoff G, Crawford AD, Sadelain M, et al. Involvement of granulocyte-macrophage colonystimulating factor in pulmonary homeostasis. Science. 1994; 264:713–6.
Article
6. Huffman JA, Hull WM, Dranoff G. Pulmonary epithelial cell expression of GM-CSF corrects the alveolar proteinosis in GM-CSF-deficient mice. J Clin Invest. 1996; 97:649–55.
Article
7. Park MS, Jung SC, Jin MI, et al. A case of pulmonary alveolar proteinosis associated with pulmonary tuberculosis. Tuberc Respir Dis. 2002; 52:411–8.
Article
8. Doki N, Hoshino T, Irisawa H, Sakura T, Miyawaki S. Acute myeloid leukemia complicated with pulmonary alveolar proteinosis at presentation. Rinsho Ketsueki. 2005; 46:522–6.
9. Martin RJ, Rogers RM, Myers NM. Pulmonary alveolar proteinosis: shunt fraction and lactic acid dehydrogenase concentrations as aids to diagnosis. Am Rev Respr Dis. 1978; 117:1059–62.
11. Honda Y, Kuroki Y, Matsuura E, et al. Pulmonary surfactant protein D in sera and bronchoalveolar lavage fluids. Am J Respir Crit care Med. 1995; 152:1860–6.
Article
12. Holbert JM, Costello P, Li W, Hoffman RM, Roqers RM. CT features of pulmonary alveolar proteinosis. AJR AM J Roentgenol. 2001; 176:1287–94.
Article
13. Bonfield TL, Russell D, Burgess S, Malur A, Kavuru MS, Thomassen MJ. Autoantibodies against granulocyte macrophage colonystimulating factor are diagnostic for pulmonary alveolar proteinosis. AM J Respi Cell Mol Biol. 2002; 27:481–6.
Article
14. Cordonnier C, Fleury-Feith J, Escudier E, Atassi K, Bernaudin JF. Secondary proteinosis is reversible cause of respiratory failure in leukemic patients. Am J Respir Crit Care Med. 1994; 149:788–94.
15. Venkateshiah SB, Yan TD, Bonfield TL, et al. An open-label trial of granulocyte macrophage colony stimulating factor therapy for moderate symptomatic pulmonary alveolar proteinosis. Chest. 2006; 130:227–37.
Article